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Introduction {#sec005}
============

Diabetic Mellitus is a non-communicable heterogeneous group of metabolic disorders with elevated blood glucose and abnormally shifted carbohydrate, fat and protein metabolism resulting from defects in insulin secretion and/or insulin action \[[@pone.0238094.ref001]\]. Both acute and chronic complications are responsible for the death and hospitalization associated with diabetes. Hypoglycemia, which is defined as "an abnormally low plasma glucose concentration (\<70 mg/dl) that exposes the subject to potential harm", is one of the acute complications of diabetes mellitus \[[@pone.0238094.ref002], [@pone.0238094.ref003]\].

A systemic review and meta-analysis conducted among type II DM patients reported the prevalence of mild/moderate and severe hypoglycemia to be 45%, 6% respectively \[[@pone.0238094.ref004]\]. Another multi-center study that aimed to assess rates and predictors of hypoglycemia reported that 83.0% of patients with type I DM and 46.5% of patients with type II DM experienced hypoglycemia \[[@pone.0238094.ref005]\].

Hypoglycemia poses a significant economic burden on the health care system through frequent emergency room visits, ambulance utilization, and hospitalizations costs. An estimated 2--4% of people with type 1 diabetes mellitus die from this complication of DM each year \[[@pone.0238094.ref006]--[@pone.0238094.ref011]\].

Insulin therapy, insulin secretagogues, skipping a meal, doing physical exercise without taking food, a history of severe hypoglycemia, alcoholic beverages, renal insufficiency, coronary artery disease, and infections are the most common reasons for the recurrent episodes of hypoglycemia \[[@pone.0238094.ref012]--[@pone.0238094.ref015]\].

The spectrum of symptoms depends on the duration and severity of hypoglycemia and vary from autonomic activation to behavioral changes to altered cognitive function. Checking blood glucose levels is the only way to know whether a person is experiencing low blood glucose. The short and long-term complications include neurologic damage, trauma, cardiovascular events, and death \[[@pone.0238094.ref006], [@pone.0238094.ref012]\].

Hypoglycemia treatment requires the ingestion of glucose or carbohydrate-containing foods. Pure glucose is the preferred treatment, but any other form of carbohydrate which contains glucose will help to raise blood glucose. Glucagon is indicated for the treatment of hypoglycemia in people unable or unwilling to consume carbohydrates by mouth \[[@pone.0238094.ref014], [@pone.0238094.ref016]\]. However, early detection and prevention are preferred to its treatment to avoid severe negative health sequela and economic burden \[[@pone.0238094.ref017]\].

Effective approaches known to reduce the risk of hypoglycemia include patient education along with self-monitoring of blood glucose (SMBG), dietary modifications and regular exercise, medication adjustment, careful glucose monitoring by the patient, and conscientious follow up by the clinician \[[@pone.0238094.ref018], [@pone.0238094.ref019]\]. Moreover, knowledge about symptoms of hypoglycemia is an important step to self-care practice, because informed people are more likely to have better practice \[[@pone.0238094.ref020]\]. Having good knowledge about hypoglycemia is positively associated with good hypoglycemia prevention practice \[[@pone.0238094.ref021]\].

Several cross-sectional studies on knowledge of hypoglycemia symptoms reported as being poor or good. Research findings showed that 64.4% of diabetic patients had good knowledge of hypoglycemia \[[@pone.0238094.ref022]\], while some studies done in a rural population indicated that 63.33% of diabetic patients had inadequate knowledge \[[@pone.0238094.ref023]\]. However, some other studies showed that more than half of the study participants had knowledge about symptoms associated with hypoglycemia \[[@pone.0238094.ref024], [@pone.0238094.ref025]\]. In other study conducted in Ethiopia, 63.2% of participants had good hypoglycemia prevention practice \[[@pone.0238094.ref021]\]. They recommended educating the patient as one strategy to have a better practice on the prevention of hypoglycemia.

Even though there are many research works reported on self-care practice and knowledge about hypoglycemia, there are no studies done on knowledge and practice regarding hypoglycemia prevention among DM patients who are on regular follow up at the University of Gondar Referral and Teaching Hospital. Therefore, the current study aimed at assessing the status of knowledge and practices among diabetic patients towards the prevention of hypoglycemia and its complication at the University of Gondar Referral and Teaching Hospital (UoGRTH).

Methods {#sec006}
=======

Study area {#sec007}
----------

The study was conducted at the chronic outpatient department (OPD) of the University of Gondar Referral and Teaching Hospital (UoGRTH), which is located in Gondar town, Amhara national regional state, which is 750 km far from Addis Ababa, North-west Ethiopia. The hospital serves for more than 7 million people, who are found in central, north, and west Gondar zones and the surrounding zones and woredas. It has 680 beds and 21 wards for inpatients, emergency, and outpatient department services.

### Study design and period {#sec008}

A hospital-based cross-sectional study was conducted from February-March 2019.

### Population {#sec009}

*Source population*. All diabetic patients who were attending chronic OPD at UoGRTH.

*Study population*. All diabetic patients who were attending at UoGRTH chronic OPD during the study period.

### Inclusion and exclusion criteria {#sec010}

*Inclusion criteria*. All adult diabetic patients who were attending chronic OPD.

*Exclusion criteria*. Patients who were seriously ill and unable to communicate, patients who were unwilling to participate, and women with gestational diabetes.

### Sample size & sampling methods {#sec011}

A single population proportion formula was used to calculate sample size, n = z ^2^p (1-p)/d^2^, by considering P = 50% precession (d), 5% marginal error and 95% confidence interval. After adding a 10% contingency on the calculated 384 patients, the final sample size became 422. The daily average number of ambulatory diabetic patients visiting the outpatient department was estimated to be between 110 and 130. Systematic random sampling was done with a sampling interval of 5. Every fifth patient coming to the OPD was selected by starting from a random number.

### Data collection tools {#sec012}

A structured questionnaire was adapted from different literatures \[[@pone.0238094.ref006], [@pone.0238094.ref021], [@pone.0238094.ref023], [@pone.0238094.ref026]\]. It consists of data regarding knowledge and practices related to the prevention of hypoglycemia, socio-demographic variables, and clinical characteristics. The knowledge assessment questionnaire has 10 questions with a maximum of 12 points which was calculated by giving one for each correct response and zero for each wrong response, except for question number three which has two correct answers; so, it has two points. The practice part of the questionnaire has 15 questions with a maximum score of 17. It was calculated by giving one for each correct response and zero for each wrong response except the first question which has two points.

### Study variables {#sec013}

*Dependent variables*. Hypoglycemia prevention practice

*Independent variables*. Socio-demographic variables (age, sex, income, marital status, education, religion, and occupation). Clinical characteristics-related variables (body mass index (BMI), Types of DM, duration of treatment, type of medication used, frequency of taking medication, history of hypoglycemia, and co-morbidity).

Operational definitions {#sec014}
-----------------------

-   Good Knowledge: a score of \> 6 on the knowledge assessment questions.

-   Poor Knowledge: a score of \< 6 on the knowledge assessment questions.

-   Good Practice: a score of \>8.5 on the practice assessment questions.

-   Poor practice: a score of \< 8.5 on the practice assessment questions.

### Data collection procedures {#sec015}

A structured questionnaire was developed in English and translated to Amharic, which was the language spoken by the study subjects. It was back-translated to English by another person to check for consistency. Three pharmacy technicians and one clinical pharmacist were recruited for data collection and supervision, respectively. The questionnaire was pretested on 21 diabetic patients in the same set up who were not included in the main study. The original questionnaire was modified for clarity, sensitiveness, and completeness based on the pre-test data.

### Data processing and analysis {#sec016}

Data analysis was done by using International Business Machines Corporation, Statistical Package for the Social Sciences (IBM SPSS) version 20). Descriptive analysis was done. Frequency distribution and percentage were used to describe results on the knowledge and practice of hypoglycemia prevention. Associated factors were identified using binary logistic regression analysis. Variables with p-value of less than 0.3 from bivariate analysis were taken to multivariate logistic regression analysis and a p-value \< 0.05 was considered as statistically significant.

### Ethical consideration {#sec017}

The study was conducted after ethical approval of the proposal from the University of Gondar, School of Pharmacy ethics committee (Ref.N[o]{.ul}:SOP318/2011). A letter of cooperation was obtained from the chief medical director. Since there were so many illiterate participants and finding a witness for every illiterate individual was difficult, we took verbal informed consent from each study participant. Data was taken anonymously and kept confidential throughout the study period.

Results {#sec018}
=======

Sociodemographic variables and clinical characteristics of study subjects' {#sec019}
--------------------------------------------------------------------------

A total of 422 DM patients participated in this study. The mean age of respondents was 42.23 (SD±16) years. More than half (61.6%) of them were male. Two-hundred and seventy (64%) participants were married. The majority (85.1%) of the participants were Orthodox Christian followers. Two-hundred and ninety-six (70.1%) of them were urban residents. Regarding their education status, 38.6% were illiterate and the rest completed primary school and above. Two-third (67.3%) of the study subjects had a normal BMI. Two-hundred and twenty-eight (54%) of the study subjects were type II diabetes mellitus patients and 17% of participants were comorbid with hypertension. Approximately 71% of the participant experienced insulin injection therapy and the rest were on oral hypoglycemic agents. In addition, 46.4% of the participant took their medications for more than five years (Tables [1](#pone.0238094.t001){ref-type="table"} and [2](#pone.0238094.t002){ref-type="table"}).

10.1371/journal.pone.0238094.t001

###### Socio demographic characteristic of study participants, UoGRTH, North-West Ethiopia, 2019 (N = 422).

![](pone.0238094.t001){#pone.0238094.t001g}

  Variable             Classification                                 Frequency (%)
  -------------------- ---------------------------------------------- ---------------
  Age                  18--34                                         154 (36.5%)
                       35--64                                         220 (52.1%)
                       \> 65                                          48 (11.4%)
  Sex                  Male                                           260 (61.6%)
                       Female                                         162 (38.4%)
  Residence            Urban                                          296 (70.1%)
                       Rural                                          126 (29.9%)
  Religion             Orthodox                                       359 (85.1%)
                       Muslim                                         56 (13.3%)
                       Protestant                                     7 (1.7%)
  Marital status       Unmarried                                      97 (23%)
                       Married                                        270 (64%)
                       Divorced                                       21 (5%)
                       Widowed                                        34 (8.1%)
  Educational status   Unable to write and read                       160 (37.9%)
                       Primary education                              112 (26.5%)
                       Secondary education                            87 (20.6%)
                       College and above                              63 (14.9%)
  Occupation           Unemployed                                     102 (24.2%)
                       Private                                        100 (23.7%)
                       Government                                     85 (20.1%)
                       Student                                        35 (8.3%)
                       House wife                                     41 (9.7%)
                       Farmer                                         59 (14%)
  Income per month     \<15USD[\*](#t001fn001){ref-type="table-fn"}   263 (62.3%)
                       15--30 USD                                     49 (11.6%)
                       30-45USD                                       24 (5.7%)
                       \>45USD                                        86 (20.4%)

\*USD---United states dollar

10.1371/journal.pone.0238094.t002

###### Clinical characteristics of the study participants, UoGRTH, Northwest-Ethiopia, 2019 (N = 422).

![](pone.0238094.t002){#pone.0238094.t002g}

  Variable                                    Classification                               Frequency
  ------------------------------------------- -------------------------------------------- -------------
  BMI                                         \< 18.5                                      51 (12.1%)
                                              18.5--24.5                                   284 (67.3%)
                                              25--29.9                                     79 (18.7%)
                                              \>30                                         8 (1.9%)
  Types of diabetes                           Type I                                       194 (46%)
                                              Type II                                      228 (54%)
  Duration with illness (DM) in year          1--2                                         102 (24.2%)
                                              3--5                                         124 (29.4%)
                                              \>5                                          196 (46.4%)
  Types of treatment                          Insulin                                      298 (70.6%)
                                              Metformin                                    74 (17.5%)
                                              Metformin + Glibenclamide                    34 (8.1%)
                                              Insulin + metformin                          16 (3.8%)
  Frequency of taking medication              Once a day                                   30 (7.1%)
                                              Twice a day                                  392 (92.9%)
  History of hypoglycemia in the last month   yes                                          16 (3.8%)
                                              No                                           406 (96.2%)
  Co-morbid condition                         Hypertension                                 75 (17.8%)
                                              Dyslipidemia                                 15 (3.6%)
                                              Hypertension and dyslipidemia                23 (5.5%)
                                              Heart failure                                2 (0.5%)
                                              Other[\*](#t002fn001){ref-type="table-fn"}   8 (1.9%)
                                              None                                         299 (70.9%)

\* Epilepsy, peptic ulcer disease, hyperthyroidism, stroke, constipation, endocarditis, dermatitis, osteoarthritis.

Knowledge about hypoglycemia prevention {#sec020}
---------------------------------------

Of all the participants, 327 of them (77.5%) had good knowledge about hypoglycemia prevention. Most (82.2%) of the participants knew about the blood glucose level below which it is termed hypoglycemia. The majority (90.5%) of the study subjects correctly answered questions with regard to the causes of hypoglycemia. Three-hundred fifty-four (83.9%) of the study subjects knew the symptoms of hypoglycemia and 295 (69.9%) of the participants knew about ways to prevent hypoglycemia ([Table 3](#pone.0238094.t003){ref-type="table"}).

10.1371/journal.pone.0238094.t003

###### Knowledge regarding hypoglycemia prevention among study subjects, UoGRTH, North-west Ethiopia, 2019 (N = 422).

![](pone.0238094.t003){#pone.0238094.t003g}

  Variable                                 Good knowledge response N (%)   Poor knowledge response N (%)
  ---------------------------------------- ------------------------------- -------------------------------
  low blood glucose level (Hypoglycemia)   347(82.2)                       75 (17.8)
  Normal blood glucose level               247 (58.5)                      175 (41.5)
  Main cause of hypoglycemia               382 (90.5)                      40 (9.5)
  Risk factor for hypoglycemia             243 (57.6)                      179 (42.4)
  Symptoms of hypoglycemia                 354 (83.9)                      68 (16.1)
  Symptoms of night time hypoglycemia      156 (37)                        266 (63)
  Complication of hypoglycemia             390 (92.4)                      32 (7.6)
  Ways to Prevent hypoglycemia             295 (69.9)                      127 (30.1)
  Prevent night time hypoglycemia          211 (50)                        211 (50)
  Prevent repeated hypoglycemia            193 (45.7)                      229 (54.3)
  Total Knowledge assessment               327 (77.5) Good Knowledge       95 (22.5) poor knowledge

Practice experience on hypoglycemia prevention {#sec021}
----------------------------------------------

Among the respondents, 393 (93.1%) had good practice in hypoglycemia prevention. For example, the majority (87.2%) of participants responded that they carry simple sugar while traveling. Similarly, 74 (17.5%) participants reported that they monitor their blood glucose level at home, and few (8.8%) participants practiced re-testing their blood glucose after managing a hypoglycemia incident. Almost all (95.5%) of participants were adherent towards the regular appointments, and the majority (93.3%) of participants reported hypoglycemia episodes to their physician (See [Table 4](#pone.0238094.t004){ref-type="table"}).

10.1371/journal.pone.0238094.t004

###### Practice regarding hypoglycemia prevention among ambulatory diabetic patients, UoGRTH, North-west- Ethiopia, 2019 (N = 422).

![](pone.0238094.t004){#pone.0238094.t004g}

  Variables                                              Good practice response N (%)   Poor practice response N (%)
  ------------------------------------------------------ ------------------------------ ------------------------------
  Have table sugar while travelling                      368 (87.2)                     42 (10)
  Self-management of hypoglycemia                        344 (81.5)                     78 (18.5)
  When did you experience hypoglycemia                   336 (79.6)                     86 (20.4)
  Safe exercise to avoid hypoglycemia                    390 (92.9)                     30 (7.1)
  Duration of exercise                                   278 (65.9)                     144 (34.1)
  Effect of weight lifting in a hypoglycemic patient     261(61.8)                      161 (38.2)
  Self-blood glucose monitoring at home                  74 (17.5)                      348 (82.5)
  Measure blood glucose when you think hypoglycemic      187 (44.3)                     235 (55.7)
  Retest blood glucose after treatment of hypoglycemia   37 (8.8)                       385 (91.2)
  Taking snacks                                          137 (32.5)                     285 (67.5)
  Irregular carbohydrate diet                            62 (14.7)                      360 (85.3)
  Coming in regular appointment                          403 (95.5)                     19 (4.5)
  Adjust medication based on blood glucose level         243 (57.6)                     179 (42.4)
  Report hypoglycemia episodes to a physician            394 (93.3)                     28 (6.6)
  Total practice assessment                              393 (93.1) Good                29 (6.9) Poor

Factors associated with practice on hypoglycemia prevention {#sec022}
-----------------------------------------------------------

Bivariate logistic regression analysis showed that gender (P = 0.08), educational status (P = 0.084), occupation (P = 0.013), duration of the illness (P = 0.082), the type of treatment given (P = 0.046), and the level of knowledge about prevention of hypoglycemia (p = 0.001) were factors possibly associated with the practice of hypoglycemia prevention. However, only the level of knowledge of hypoglycemia prevention showed statistically significant association (p = 0.01; AOR: 2.87 95%CI (1.2--6.8) on multivariate regression (See [Table 5](#pone.0238094.t005){ref-type="table"}).

10.1371/journal.pone.0238094.t005

###### Factors associated with hypoglycemia prevention practice among study subjects, UoGRTH, North-west- Ethiopia, 2019 (N = 422).

![](pone.0238094.t005){#pone.0238094.t005g}

  Variable                         Practice regarding prevention of hypoglycemia   P value     COR     AOR (95% CI)   P value      
  -------------------------------- ----------------------------------------------- ----------- ------- -------------- ------------ -------
  Age                                                                                          0.55                                
  18--34                           145 (36.9)                                      9 (31)      0.28    1.00                        
  35--64                           205 (52.2)                                      15 (51.7)   0.39    0.533                       
  \>65                             43 (10.9)                                       5 (17.2)    0.00    0.629                       
  Sex                                                                                                                              
  Male                             249 (63.4)                                      11 (37.9)   0.008   0.353          2.39         0.10
  Female                           144 (36.6)                                      18 (62.1)                                       9
  Residence                                                                                                                        
  Urban                            277 (70.5)                                      19 (65.5)   0.573   0.795                       
  Rural                            116 (29.5)                                      10 (34.5)                                       
  Marital status                                                                               0.396                               
  Unmarried                        94 (23.9)                                       3 (10.3)    0.187   1.00                        
  Married                          248 (63.1)                                      22 (75.9)   0.892   0.329                       
  Divorce                          20 (5.1)                                        1 (3.4)     0.578   0.916                       
  Widowed                          31 (7.9)                                        3 (10.3)    0.000   0.516                       
  Educational status                                                                           0.084                               
  Unable to write and read         143 (36.4)                                      17 (58.6)   0.075   1.00           2.53         0.182
  Primary education                107 (27.2)                                      5 (17.2)    0.033   0.393          6.80         0.061
  Secondary education              85 (21.6)                                       2 (6.9)     0.545   0.197          1.83         0.539
  Graduate                         58 (14.8)                                       5 (17.2)    0.000   0.725                       
  Occupation                                                                                   0.013                  2.59         0.25
  Unemployed                       98 (24.9)                                       4 (13.8)    0.426   1.00           1.27         0.77
  Private employed                 96 (24.4)                                       4 (13.8)    0.443   0.561          0.55         0.60
  Government employed              79 (20.1)                                       6 (20.7)    0.948   0.572          0.59         0.65
  Student                          33 (8.4)                                        2 (6.9)     0.838   1.044          0.57         0.51
  House wife                       32 (8.1)                                        9 (31)      0.034   0.833                       
  Farmer                           55 (14)                                         4 (13.8)    0.000   3.867                       
  Income                                                                                       0.871                               
  \<15USD                          244 (62.1)                                      19 (65.5)   0.938   1.00                        
  15-30USD                         47(12)                                          2 (6.9)     0.498   1.03                        
  30-45USD                         22 (5.6)                                        2 (6.9)     0.821   0.56                        
  \>45USD                          80 (20.4)                                       6 (20.7)    0.000   1.21                        
  BMI                                                                                                                              
  \<18.5                           40 (12.2)                                       11 (11.6)   0.844                               
  18.5--24.9                       220 (67.3)                                      64 (67.4)                                       
  25--29.9                         62 (19)                                         17 (17.9)                                       
  \>30                             5 (1.5)                                         3 (3.2)                                         
  Type of DM                                                                                                                       
  Type I                           183 (46.6)                                      11 (37.9)   0.370   0.70                        
  Type II                          210 (53.4)                                      18 (62.1)                                       
  Diabetic duration in year                                                                    0.082                               
  1--2                             92 (23.4)                                       10 (34.5)   0.634   1.00           0.40         0.07
  3--5                             121 (30.8)                                      3 (10.3)    0.046   1.22           3.70         0.05
  \>5                              180 (45.8)                                      16 (55.2)   0.00    0.27                        
  Type of treatment                                                                            0.046                               
  Insulin                          279 (71)                                        19 (65.5)   0.349   1.00           1.77         0.51
  Metformin                        72 (18.3)                                       2 (6.9)     0.115   0.47           8.06         0.08
  Metformin + glibenclamid         28 (7.1)                                        6 (20.7)    0.644   0.19           0.64         0.66
  Insulin + metformin              14 (3.6)                                        2 (6.9)     0.010   1.50                        
  Frequency of taking medication                                                                                                   
  Once a day                       29 (7.4)                                        1 (3.4)     0.438   0.44                        
  Twice a day                      364 (92.9)                                      28 (96.6)                                       
  History of hypoglycemia                                                                                                          
  Yes                              173 (44)                                        12 (41.1)   0.782   0.89                        
  No                               220 (56)                                        17 (56.2)                                       
  Comorbid condition                                                                           0.443                               
  Hypertension                     90 (22.9)                                       8 (27.5)                                        
  Dyslipidemia                     32 (8.1)                                        6 (20.6)                                        
  Heart failure                    19 (4.8)                                        4 (13.8)                                        
  other                            10 (2.5)                                        \-                                              
  None                             280 (71.2)                                      19 (65.5)                                       
  Level of knowledge                                                                                                               
  Good                             312 (79.3)                                      15 (51.7)   0.001   0.27           2.87         0.01
  Poor                             81 (20.6)                                       14 (48.2)                          (1.2--6.8)   

P value \< 0.05 considered as scientifically significant

Discussion {#sec023}
==========

Hypoglycemia can cause serious morbidity and even death if it is severe and prolonged. Due to the deprivation of glucose in the central nervous system, the primary clinical symptoms are neuroglycopenic presentations such as confusion, fatigue, and loss of consciousness. The purpose of this study was to assess the knowledge and practice of hypoglycemic prevention of patients with diabetes mellitus. In this study, we found that more than two-thirds (72.7%) of the participants had good knowledge about hypoglycemia prevention. This finding is higher than the study conducted in South Gondar, Ethiopia (25.5%). This may be due to the fact that there is an increasing public awareness about their health status due to civilization and an increase in media coverage. The other possible reason might be differences in study participants and the study setup. Our study is conducted in a comprehensive and specialized hospital which is a university teaching hospital with a better quality of care \[[@pone.0238094.ref026]\]. Our current finding is slightly higher than the study conducted in South Africa (66.1%). This difference may be due to differences in patient demographics and possibly in time \[[@pone.0238094.ref025]\].

The knowledge of most of the study participants (82.2%) regarding low blood glucose levels (hypoglycemia) was good. This result is higher than the report from Ludhiana, India (60%) \[[@pone.0238094.ref027]\]. Less than half of the participants in our study (42.4%) were unaware of the risk factors for hypoglycemia. This is comparable with one study from India (43.4%) but slightly higher than another report from the same country (32%) \[[@pone.0238094.ref005], [@pone.0238094.ref028]\].

With respect to the knowledge of hypoglycemia symptoms, the majority of the current study subjects (83.9%) had good knowledge. It was higher when compared to the report from KwaZulu-Natal, South Africa (66%), and Karnataka, India (65%) \[[@pone.0238094.ref025], [@pone.0238094.ref028]\]. These differences may be due to differences in participants' demographics. There were more literate participants in our study (62%) than the Indian study (48%).

The majority (92.4%) of the current study participants had good knowledge about the complications of hypoglycemia which was higher when compared to the study conducted from south India which reported good knowledge for only one-third of the studied subjects. This might be due to the small sample size used in the latter study \[[@pone.0238094.ref029]\].

The majority (93.1%) of the study subjects had a good hypoglycemia prevention practice. This figure is higher than the report from south Gondar, Ethiopia (21.4%) and Tigray, Ethiopia (63.2%) \[[@pone.0238094.ref021], [@pone.0238094.ref026]\]. This difference might be due to the high accessibility of health care providers with specialty care in the current hospital.

With respect to the question "the practice on prevention of hypoglycemia while traveling", more than two-third of the current study participants (87.2%) had a good practice. This was higher than the report from south Gondar Ethiopia (36.3%) \[[@pone.0238094.ref026]\]. This difference can be explained from different perspectives. The time-gap between the study periods is one possible reason. There was increased access to health care facilities since the latter study had been conducted. Additionally, there were differences in the study setups, and most importantly, there was a huge knowledge difference about hypoglycemia among study subjects in the two studies.

Most of the current study subjects (81.5%) had good knowledge of self-management practices for hypoglycemia by immediate consumption of glucose (simple sugar). This is slightly higher than the study reported from Nigeria (67.6%) \[[@pone.0238094.ref030]\]. Forty-six percent of the study participants were diabetic for more than 5 years.

Self-monitoring of blood glucose (SMBG) was practiced by 74 (17.5%) of the current study subjects. This figure was in line with the study reported from South India (15%) and was lower than the study reported from South Africa (34%). This difference might be due to differences in health care setup and study subjects' literacy levels \[[@pone.0238094.ref029], [@pone.0238094.ref025]\]. The majority (95.5%) of participants had good practice with respect to adhering to appointment periods. Almost similar study findings were reported from south Gondar, Ethiopia (93.3%) \[[@pone.0238094.ref026]\].

Self-adjustment of medications was reported by more than half (57.6%) of the current study subjects which was higher compared to that of the South African (43%) and Indian (17%) studies \[[@pone.0238094.ref025], [@pone.0238094.ref028]\]. The difference may be due to the small sample size of these latter studies. The majority (93.3%) of study participants had a good practice of reporting hypoglycemic episodes to their doctors. This figure is higher compared to the study conducted in south India (48.6%) \[[@pone.0238094.ref029]\].

A small number (17.5%) of the current study subjects had a glucometer at their home. This was higher compared to the study report from south India (5%) and Gondar, Ethiopia (7.7%). However, it was lower than the study reported from Kwazulu-Natal, South Africa (24%), and the study report from Qatar (60.5%). This might be due to the differences in patients' economic status and their awareness regarding the importance to practice SMBG \[[@pone.0238094.ref029], [@pone.0238094.ref026], [@pone.0238094.ref031], [@pone.0238094.ref032]\].

Seventy-four (17.5%) of the current study participants reported their ability to self-monitor their glucose levels at home, even though 243 (57.6%) patients reported that they practiced self--adjustment of their medications at home. This finding suggests that some patients were self-adjusting their medication at home based on how they feel, without objectively measuring their blood sugar. This may put them at risk of developing hypoglycemia or hyperglycemia. There is a need for the provision of education about medication adjustment in DM patients \[[@pone.0238094.ref033]\].

In the current study, only having a good knowledge regarding hypoglycemia prevention was strongly associated with good hypoglycemia prevention practice (p = 0.01; AOR: 2.87). This means that patients with good knowledge were 2.87 times more likely to practice hypoglycemia prevention measures as compared to those patients with poor knowledge. This finding was in line with the study reported from Tigray, Ethiopia \[[@pone.0238094.ref021]\]. This result suggests that knowledge about hypoglycemia prevention is essential to practice hypoglycemic prevention measures.

Twenty-eight of the current study participants were hypoglycemic at the time of hospital visit which gave a prevalence of 6.6%. This was lower than different studies in the United States which reported prevalence of hypoglycemia range from 12% to 18%.This may be due to differences in the life style of the study participants between the studies. In the current study, we only used the patients' blood glucose level which they have at hand when they came for follow up. But the other studies took reported cases of hypoglycemia retrospectively \[[@pone.0238094.ref003], [@pone.0238094.ref031]\].

Even though participants had good knowledge and practice of hypoglycemia prevention strategies, a high number of participants had practice of hypoglycemia prevention without adequate knowledge of hypoglycemia prevention. This may be due to some participants may practice to prevent hypoglycemia by family support and asking some persons and even sometimes the try something by their assumption the other possible reason may be the knowledge questions were somehow it needs scientific knowledge.

Limitation {#sec024}
==========

The study design was cross-sectional. Therefore causal modeling could not be attempted. The participants were recruited from one medical center and patients who have regular visits in northwest Ethiopia. Therefore, the findings may not be generalizable to all DM patients. Future studies with a larger and more representative sample size that include patients with gestational DM and pediatric patients with DM is required.

Conclusion {#sec025}
==========

In conclusion, the practices of hypoglycemia prevention strategies among ambulatory diabetic patients were good. Knowledge of hypoglycemia prevention strategies and its practice are essential elements for control of hypoglycemia and hypoglycemic crisis. Good knowledge of hypoglycemia prevention was strongly associated with its prevention practice.

Recommendation {#sec026}
==============

The current study showed that there are still gaps with respect to knowledge about hypoglycemia prevention and its practice. Therefore, we recommend providing education about hypoglycemia in general, its complication, its treatment, and prevention strategies when they came for follow up. We recommend that this study to be done in Ethiopia as a whole so will yield an accurate result.

Supporting information {#sec027}
======================

###### 

(DOCX)

###### 

Click here for additional data file.
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:   University of Gondar Comprehensive and Specialized Hospital
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Results -- data in the figures is also presented in the table and text. Results should be selectively presented in a single format. I would also encourage you to work with a statistician - there are several analyses that could be run with this data that might be more informative than simple descriptive statistics.
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Finally, I encourage you to have this proof read by a native English speaker before resubmitting.

Reviewer \#2: The authors completed a cross-sectional study at an outpatient hospital facility in Ethiopia to determine prevalence of hypoglycemia and patients' level of knowledge about hypoglycemia and their use of various practices to prevent hypoglycemia. They discuss the results in relationship to other similar published studies and, despite a low prevalence of hypoglycemia in the study population, recommend patient education related to prevention of hypoglycemia.

This article has the potential to contribute important knowledge to the scientific literature, but not in its current form. The purpose of the study is based on the premise that this information hasn't been collected before in this population, and that knowledge of hypoglycemia is related to better prevention of hypoglycemia. While this is a cross-sectional study and is limited in the potential to determine causality, as stated by the authors in their limitations section, the relationship between a patient's knowledge score and their practice score could be investigated with these data (but is not).

As presented, the results of this study are difficult to interpret and do not seem to fully support the claim that the study group has good knowledge of hypoglycemia and practice on hypoglycemia prevention. The experimental methods and results are not described in sufficient detail. The authors state that the study questionnaire was used in another published study, but it is unclear as to whether the questionnaire is validated to measure what it is intended to measure. Additionally, the results need to be more detailed; specifically, the mean score for each component of the knowledge and practice score should be included in tables 3 and 4 so that the reader can understand how the whole group fares in terms of knowledge and practice of hypoglycemia prevention. This is important because the authors present the results as "good" or "poor" knowledge and practice based on how each individual score compares to the mean score of the group, but the results really don't show whether or not the subjects have good or poor knowledge of hypoglycemia/prevention -- they just show the proportion of the group that falls above the mean and the proportion that falls below the mean. If the entire sample group has limited knowledge and practice of hypoglycemia prevention (i.e. the mean is a low score out of the maximum), even scores that are less than half of the maximum could be considered "good" knowledge or practice scores. It seems that setting a minimum threshold score to consider as "good" knowledge or "good" practice would be a better way to present these results. Furthermore, it is unclear where the estimate that "72.7% of participants had good knowledge in hypoglycemia prevention" (line 1 of the discussion) came from, and similarly how the authors came to the conclusion that "93.1% of the patients had good practice" (discussion paragraph 3, line 1). These numbers are not indicated in the results in tables 3 or 4.

Finally, figures 1 and 2 are unnecessary and add no additional information beyond what is included in tables 1 and 2; they should be removed.

The discussion requires a revision for clarity - is messy and difficult to follow. Also, the authors attribute much of the differences between the findings in their study and the findings of other studies to differences in sample size. This should either be elaborated on, or more thoughtful discussion of potential reasons for disparate results should be considered. Are the authors suggesting that the other studies were not adequately powered to detect differences between their study groups? How specifically does this affect the interpretation of these results compared to other studies?
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Author response to Decision Letter 0

15 Feb 2020

editores comment is adressed. submitted the required three document revized manuscript, revized manuscript with trackchange and response to reviwers comment.

Journal requirment was corrected as follows

1\. manuscript meets PLOS ONE\'s style requirements, including those for file naming.

2\. rephrased any duplicated text outside the methods section.overlapping text with previous publications were revized. the consent is verbal i included in the text.

3.I already included additional information regarding the survey or questionnaire used in the study. Supporting files were attached as per recommendation

4\. About ethics statment\-\-- I removed ethics ststment form any other site except in the method section.

5\. Tables are now part of manuscript

reviwers comment

1\. first question I tried to make scientifically sound with rewritten of introduction and discussion part and proof reeding

2\. Has the statistical analysis been performed appropriately and rigorously? Now i made analysis to find out associated factors with binary logestic regression analysis. Finally new table was made and appropraitely interpreted.

3\. Is the manuscript presented in an intelligible fashion and written in standard English? I completely proff read and re written to make it easy to understand.

reviwers comment was adressed and attached as per request.

###### 

Submitted filename: Rebuttal letter.docx

###### 

Click here for additional data file.

10.1371/journal.pone.0238094.r003

Decision Letter 1

Bryner

Randy Wayne

Academic Editor

© 2020 Randy Wayne Bryner

2020

Randy Wayne Bryner

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

26 Mar 2020

PONE-D-19-25882R1

Hypoglycaemia prevention practice and its associated factors among diabetes patients at university teaching hospital in Ethiopia: cross-sectional study

PLOS ONE

Dear Mr Muche,
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Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.
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Randy Wayne Bryner, Ed.D.

Academic Editor

PLOS ONE

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:
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**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: No
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3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes
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5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: No

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: Thank you for revising your manuscript. The introduction still does not fully justify this study - if you\'re running multivariate regressions it indicates you\'re trying to find predictors - that needs to be included in the introduction. In the current version the operational definitions are still unclear. You state that Poor knowledge or practice is when patients scored below 50% of the mean score. That implies that 50% of the population will have \"good\" and the other half will have \"poor\" knowledge or practice. The threshold for good and bad should not be based on the population - if the entire sample scores \<25% correct that would suggest nobody had good practice or knowledge, but according to your operational definition the top 50% would still be classified as \"good\". However, when reading the results it seems this is not, in fact, how you are using \"good\" or \"poor\" since 77.% had good knowledge of hypoglycemia prevention. Please clarify your operational definition. The units of birr will not make sense to readers outside of the study area - perhaps you could stratify based on the average income of the area. The limitation section acknowledges that these findings are limited to the region under study, but it\'s also limited to patients that regularly visit the hospital. There are likely a great number of individuals with diabetes that do not visit the clinic regularly and are therefore less likely to be monitoring blood sugar. This manuscript still needs to be revised and proofread by a native English speaker.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Author response to Decision Letter 1
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Response to reviewer

1\. Introduction should include predictors to hypoglycemia prevention practice.

� As far as investigators knowledge there is no literatures which showed predictors of hypoglycemia prevention practice except reference 21 and 26. And these reference are reviewed under paragraph 8 under introduction.

2\. Operational definition still unclear?

Now it becomes clarified

� Good Knowledge: when patients scored \> 6 on the knowledge assessment questions.

� Poor Knowledge: when patients scored \< 6 on the knowledge assessment questions.

� Good Practice: when patients scored \>8.5 on the practice assessment questions.

� Poor practice: when patients scored \< 8.5 on the practice assessment questions.

3\. Economic status should be stratified based on the average income and change to international currency.

� This stratification is based on the study area salary scale. But we changed with USD by considering current currency exchange.

4\. These findings are limited to the region under study, but it\'s also limited to patients that regularly visit the hospital.

� Accepted and stated to limitation part this study.
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Dear Dr. Muche,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

In particular, there are several typing and grammatical errors, etc. that detract from the scientific merit of this work. For the manuscript to be consider it is imperative that it be thoroughly reviewed and edited by a native English speaker.

Please submit your revised manuscript by Jul 11 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <plosone@plos.org>. When you\'re ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled \'Manuscript\'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

We look forward to receiving your revised manuscript.

Kind regards,

Randy Wayne Bryner, Ed.D.

Academic Editor

PLOS ONE
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Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: No

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: Thank you for addressing and sufficiently responding to the requested revisions. Other than a careful review and edit by a native English speaker I have no other comments.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0238094.r006

Author response to Decision Letter 2

7 Jun 2020
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Dear Dr. Muche,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

It appears that the authors are ignoring the reviewers comments to have the manuscript carefully edited by a native English speaking individual. There are still several grammatical mistakes that need to be corrected before it can be considered for publication.

Please submit your revised manuscript by Jul 27 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <plosone@plos.org>. When you\'re ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled \'Manuscript\'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

We look forward to receiving your revised manuscript.
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Randy Wayne Bryner, Ed.D.

Academic Editor

PLOS ONE
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Dear Dr. Muche,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.
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Randy Wayne Bryner, Ed.D.

Academic Editor
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Dear Dr. Muche:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.
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PLOS ONE Editorial Office Staff

on behalf of

Dr. Randy Wayne Bryner
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